Pediatric Epworth Sleepiness Scale (Ess Chad) Calculator

What Is the Pediatric Epworth Sleepiness Scale (ESS-CHAD)?

The Epworth Sleepiness Scale for Children and Adolescents (ESS-CHAD) is a validated, self-report questionnaire designed to measure daytime sleepiness in pediatric patients aged 2 to 18 years. Developed as a child-adapted version of the original adult Epworth Sleepiness Scale, the ESS-CHAD asks respondents — or their parents — to rate the likelihood of dozing off in eight common daily situations. Clinicians use the total score to screen for excessive daytime sleepiness (EDS), a hallmark symptom of pediatric sleep disorders such as obstructive sleep apnea (OSA), narcolepsy, and idiopathic hypersomnia.

The ESS-CHAD Formula

The total ESS-CHAD score is the arithmetic sum of eight individual situation ratings:

ESS-CHAD = s1 + s2 + s3 + s4 + s5 + s6 + s7 + s8

Each situation (s_i) is rated on a 4-point Likert scale:

• 0 — Would never doze
• 1 — Slight chance of dozing
• 2 — Moderate chance of dozing
• 3 — High chance of dozing

Total scores range from 0 to 24, with higher scores indicating greater daytime sleepiness.

The Eight Rated Situations

Respondents rate the chance of dozing in each of the following standardized scenarios:

1. Sitting and reading
2. Watching television
3. Sitting inactive in a public place (e.g., a classroom or theater)
4. Riding as a passenger in a car for one hour without a break
5. Lying down to rest in the afternoon when circumstances permit
6. Sitting and talking to someone
7. Sitting quietly after lunch without having consumed alcohol
8. Sitting in a car stopped briefly in traffic

Score Interpretation

Clinical research supports the following ESS-CHAD score thresholds for interpreting results in children and adolescents:

• 0–9: Normal range — typical daytime alertness expected for the pediatric population
• 10–15: Mild to moderate excessive daytime sleepiness — warrants clinical attention and possible referral for a sleep study
• 16–24: Severe excessive daytime sleepiness — strongly associated with pediatric sleep disorders; prompt specialist evaluation is recommended

A score of 10 or above is the widely accepted clinical cutoff for identifying EDS in children and adolescents, consistent with thresholds established in validation studies of the ESS-CHAD.

Clinical Use Cases

The ESS-CHAD serves multiple evidence-based clinical purposes across pediatric medicine:

• Screening: Identifies children at risk for sleep-disordered breathing, narcolepsy, or insufficient sleep syndrome during routine well-child visits
• Treatment monitoring: Tracks changes in daytime sleepiness before and after interventions such as adenotonsillectomy, CPAP therapy, or behavioral sleep programs
• Research: Provides a standardized, reproducible measure of daytime sleepiness for use in pediatric sleep studies and clinical trials

Example Calculation

A 13-year-old's parent rates the following situations: reading (1), TV (2), classroom (2), car passenger (1), afternoon rest (3), talking (0), after lunch (2), stopped in traffic (1). The ESS-CHAD score equals 1+2+2+1+3+0+2+1 = 12, indicating moderate excessive daytime sleepiness and warranting further clinical evaluation by a pediatric sleep specialist.

Methodology and Validation

The ESS-CHAD has undergone rigorous psychometric validation across diverse pediatric populations. According to validation research published via PubMed Central, the ESS-CHAD demonstrates strong internal consistency (Cronbach's alpha typically exceeding 0.80) and convergent validity with objective sleep measures including the Multiple Sleep Latency Test (MSLT) and polysomnographic indices of sleep architecture. A complementary study using Rasch analysis, available through Academia.edu, confirms the scale exhibits unidimensionality and robust item fit across age groups within the pediatric range.

Reliability and Item Performance: Test-retest reliability coefficients for the ESS-CHAD generally fall in the 0.80–0.90 range when administered 2–4 weeks apart, supporting its stability as a clinical outcome measure. Individual situation items demonstrate differential performance across age groups, with younger children (ages 2–6) showing more parental-proxy dependency, while adolescents aged 12–18 exhibit self-report reliability comparable to adult populations. This developmental variation is accounted for in clinical interpretation guidelines that recommend proxy completion for children younger than approximately 12 years.

Diagnostic Accuracy: In pediatric populations with confirmed obstructive sleep apnea diagnosed via overnight polysomnography, the ESS-CHAD cutoff score of 10 demonstrates sensitivity ranging from 0.70 to 0.85 and specificity from 0.75 to 0.90, depending on the age cohort studied and the sleep disorder in question. These performance metrics support its utility as a screening tool in primary care and sleep specialty settings, though it is not intended as a sole diagnostic criterion without confirmatory sleep testing.

Cross-Cultural Adaptations: The ESS-CHAD has been translated and validated in multiple languages and cultural contexts, including European, Asian, and Latin American pediatric populations. These international adaptations maintain the core eight-situation framework while allowing for culturally appropriate linguistic modifications that preserve the scale's reliability and validity across diverse backgrounds.

For further clinical context and developer background, the official ESS-CHAD resource page maintained by the scale's developers provides authoritative guidance on appropriate administration, scoring, and interpretation for clinical practice and research applications.